[go: up one dir, main page]

CA2191746A1 - [a]-annelated pyrrole derivatives and pharmaceutical use thereof - Google Patents

[a]-annelated pyrrole derivatives and pharmaceutical use thereof

Info

Publication number
CA2191746A1
CA2191746A1 CA002191746A CA2191746A CA2191746A1 CA 2191746 A1 CA2191746 A1 CA 2191746A1 CA 002191746 A CA002191746 A CA 002191746A CA 2191746 A CA2191746 A CA 2191746A CA 2191746 A1 CA2191746 A1 CA 2191746A1
Authority
CA
Canada
Prior art keywords
annelated
pharmaceutical use
pyrrole derivatives
diseases
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002191746A
Other languages
French (fr)
Other versions
CA2191746C (en
Inventor
Stefan Laufer
Hans Gunther Striegel
Gerd Dannhardt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merckle GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4419247A external-priority patent/DE4419247A1/en
Application filed by Individual filed Critical Individual
Publication of CA2191746A1 publication Critical patent/CA2191746A1/en
Application granted granted Critical
Publication of CA2191746C publication Critical patent/CA2191746C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to heterocyclic compounds of the formula (see formula I) in which R1-R7, B, a and X have the meanings recited in the specification.
These compounds are usable in the treatment of diseases of the rheumatoid group and for the prevention of allergically induced diseases.
CA002191746A 1994-06-01 1995-05-31 [a]-annelated pyrrole derivatives and pharmaceutical use thereof Expired - Fee Related CA2191746C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4419247A DE4419247A1 (en) 1994-06-01 1994-06-01 New pyrrolizine keto-acid, keto-ester and carboxamide derivs.
DEP4419247.9 1994-06-01
PCT/EP1995/002079 WO1995032972A1 (en) 1994-06-01 1995-05-31 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF

Publications (2)

Publication Number Publication Date
CA2191746A1 true CA2191746A1 (en) 1995-12-07
CA2191746C CA2191746C (en) 2007-04-10

Family

ID=38007168

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002191746A Expired - Fee Related CA2191746C (en) 1994-06-01 1995-05-31 [a]-annelated pyrrole derivatives and pharmaceutical use thereof

Country Status (1)

Country Link
CA (1) CA2191746C (en)

Also Published As

Publication number Publication date
CA2191746C (en) 2007-04-10

Similar Documents

Publication Publication Date Title
CA2191747A1 (en) (a)-annelated pyrrole derivatives and pharmaceutical use thereof
AU2673095A (en) {a}-annelated pyrrole derivatives and pharmaceutical use thereof
CA2263561A1 (en) Thienopyrimidines
HUP9701694A3 (en) Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds
HUP9902805A3 (en) Use of macrocyclic bis(indolyl)-maleimide derivatives for the preparation of pharmaceutical compositions treating ocular diseases
IL108648A0 (en) Condensed five-membered heterocyclic compounds, their preparation and pharmaceutical compositions containing them
AU9049391A (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity
AU661017B2 (en) N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
CA2219359A1 (en) Hydantoin derivatives as intermediates for pharmaceutical active compounds
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
AU1727297A (en) Application of pyrrolidine derivatives to the preparation of medicaments intended to the treatment of drug abuse
CA2191746A1 (en) [a]-annelated pyrrole derivatives and pharmaceutical use thereof
AU1727397A (en) Application of pyrrolidine derivatives to the preparation of medicaments for the treatment of drug abuse
FR2700546B1 (en) Imidazo [2,1-b] benzoxazole-3-acetamide derivatives, their preparation and their therapeutic use.
AU2626392A (en) Use of substituted pyrrolidines, some of which are known, as medicaments, new active substances and processes for their preparation
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
AU1417592A (en) Heterocyclic compounds, their preparation and pharmaceutical use
FR2700543B1 (en) Salts of 4-pyrimidinone derivatives, their preparation and their therapeutic use.
FR2703355B1 (en) 2-Aminopyrimidine-4-carboxamide derivatives, their preparation and their therapeutic use.
FR2698364B1 (en) Pyrrole derivatives, their preparation and their therapeutic application.
GB9223738D0 (en) Heterocyclic compounds,their preparation and pharmaceutical use
GB9210489D0 (en) Heterocyclic compounds,their preparation and pharmaceutical use
IL119421A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
AU708571C (en) Novel heterocyclic derivatives and pharmaceutical use thereof
FR2700547B1 (en) Imidazo [2,1-b] benzoselenazole-3-acetamide derivatives, their preparation and their therapeutic use.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed